The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, February 27, 2019
Heron Therapeutics announced the FDA has approved Heron's sNDA for CINVANTI (aprepitant) injectable emulsion, for intravenous use.
read more
Wednesday, February 27, 2019
Janssen Research & Development
Janssen Pharmaceutical announced the FDA has approved TREMFYA® One-Press, a single-dose, patient-controlled injector for adults with moderate-to-...
read more
Wednesday, February 27, 2019
IBSA Pharma announced its Tirosint-SOL (levothyroxine sodium) oral solution is now available in the US market for the treatment of hypothyroidism and ...
read more
Tuesday, February 26, 2019
ROMEG Therapeutics announced the FDA approved GLOPERBA (colchicine) Oral Solution, 0.6 mg/5 mL for prophylaxis of gout flares in adults.
read more
Thursday, February 21, 2019
Indivior has launched an authorized generic version of SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) in the U.S.
read more
Friday, February 15, 2019
The FDA permitted marketing of the Tandem Diabetes Care t:Slim X2 insulin pump with interoperable technology for delivering insulin under the skin for...
read more
Wednesday, February 13, 2019
Mylan announced the launch of the first FDA-approved therapeutically equivalent, substitutable generic of ADVAIR DISKUS, Wixela Inhub, approved by the...
read more
Tuesday, February 12, 2019
Janssen Research & Development
Janssen Pharmaceutical announced the FDA has approved a split-dosing regimen for DARZALEX, providing healthcare professionals and patients with ...
read more
Thursday, February 07, 2019
Dr. Reddy’s Laboratories announced it is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram Sodium Chloride Injection single-...
read more
Thursday, February 07, 2019
AIVITA Biomedical announced findings which indicate a mechanism of action for its ROOT OF CANCER technology.
read more
Monday, February 04, 2019
Biohaven announced that administration of intranasal BHV-3500 in a Phase 1 clinical trial has achieved targeted therapeutic exposures and that the ...
read more
Thursday, January 31, 2019
The FDA approved the first generic of Advair Diskus for the twice-daily treatment of asthma and maintenance treatment of COPD.
read more
Wednesday, January 30, 2019
One of our key policy priorities is encouraging the timely development and approval of generics and biosimilars.
read more
Q BioMed announced its technology partner, Mannin Research, has initiated a collaboration with McMaster University of Ontario, Canada.
read more
Dr. Reddy’s announced the launch of Propofol Injectable Emulsion, USP, a therapeutic equivalent generic version of DIPRIVAN Injectable Emulsion, USP, ...
read more